166 related articles for article (PubMed ID: 16916640)
1. Engineered hybrid dimers: tracking the activation pathway of caspase-7.
Denault JB; Békés M; Scott FL; Sexton KM; Bogyo M; Salvesen GS
Mol Cell; 2006 Aug; 23(4):523-33. PubMed ID: 16916640
[TBL] [Abstract][Full Text] [Related]
2. A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases.
Abhari BA; Davoodi J
J Mol Biol; 2008 Sep; 381(3):645-54. PubMed ID: 18619610
[TBL] [Abstract][Full Text] [Related]
3. Role of proteolysis in caspase-8 activation and stabilization.
Pop C; Fitzgerald P; Green DR; Salvesen GS
Biochemistry; 2007 Apr; 46(14):4398-407. PubMed ID: 17371051
[TBL] [Abstract][Full Text] [Related]
4. The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation.
Golks A; Brenner D; Schmitz I; Watzl C; Krueger A; Krammer PH; Lavrik IN
Cell Death Differ; 2006 Mar; 13(3):489-98. PubMed ID: 16179941
[TBL] [Abstract][Full Text] [Related]
5. The biochemical mechanism of caspase-2 activation.
Baliga BC; Read SH; Kumar S
Cell Death Differ; 2004 Nov; 11(11):1234-41. PubMed ID: 15297885
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
Keller N; Mares J; Zerbe O; Grütter MG
Structure; 2009 Mar; 17(3):438-48. PubMed ID: 19278658
[TBL] [Abstract][Full Text] [Related]
7. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
[TBL] [Abstract][Full Text] [Related]
8. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.
Byun Y; Chen F; Chang R; Trivedi M; Green KJ; Cryns VL
Cell Death Differ; 2001 May; 8(5):443-50. PubMed ID: 11423904
[TBL] [Abstract][Full Text] [Related]
9. Structure-based thermodynamic analysis of caspases reveals key residues for dimerization and activity.
Piana S; Sulpizi M; Rothlisberger U
Biochemistry; 2003 Jul; 42(29):8720-8. PubMed ID: 12873132
[TBL] [Abstract][Full Text] [Related]
10. The apoptosome activates caspase-9 by dimerization.
Pop C; Timmer J; Sperandio S; Salvesen GS
Mol Cell; 2006 Apr; 22(2):269-75. PubMed ID: 16630894
[TBL] [Abstract][Full Text] [Related]
11. Activation and substrate specificity of caspase-14.
Mikolajczyk J; Scott FL; Krajewski S; Sutherlin DP; Salvesen GS
Biochemistry; 2004 Aug; 43(32):10560-9. PubMed ID: 15301553
[TBL] [Abstract][Full Text] [Related]
12. Specific proteolysis of the A-kinase-anchoring protein 149 at the Asp582 residue by caspases during apoptosis.
Yoo H; Cha HJ; Lee J; Yu EO; Bae S; Jung JH; Sohn I; Lee SJ; Yang KH; Woo SH; Seo SK; Park IC; Kim CS; Jin YW; Ahn SK
Oncol Rep; 2008 Jun; 19(6):1577-82. PubMed ID: 18497968
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
[TBL] [Abstract][Full Text] [Related]
14. Delineation of the caspase-9 signaling cascade.
Guerrero AD; Chen M; Wang J
Apoptosis; 2008 Jan; 13(1):177-86. PubMed ID: 17899380
[TBL] [Abstract][Full Text] [Related]
15. Redox control of caspase-3 activity by thioredoxin and other reduced proteins.
Baker A; Santos BD; Powis G
Biochem Biophys Res Commun; 2000 Feb; 268(1):78-81. PubMed ID: 10652216
[TBL] [Abstract][Full Text] [Related]
16. Dimer formation drives the activation of the cell death protease caspase 9.
Renatus M; Stennicke HR; Scott FL; Liddington RC; Salvesen GS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14250-5. PubMed ID: 11734640
[TBL] [Abstract][Full Text] [Related]
17. Caspase activation: revisiting the induced proximity model.
Shi Y
Cell; 2004 Jun; 117(7):855-8. PubMed ID: 15210107
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy.
Putt KS; Chen GW; Pearson JM; Sandhorst JS; Hoagland MS; Kwon JT; Hwang SK; Jin H; Churchwell MI; Cho MH; Doerge DR; Helferich WG; Hergenrother PJ
Nat Chem Biol; 2006 Oct; 2(10):543-50. PubMed ID: 16936720
[TBL] [Abstract][Full Text] [Related]
19. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
20. Caspase 3 activation is controlled by a sequence located in the N-terminus of its large subunit.
Pelletier M; Cartron PF; Delaval F; Meflah K; Vallette FM; Oliver L
Biochem Biophys Res Commun; 2004 Mar; 316(1):93-9. PubMed ID: 15003516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
